Return On Equity of eFFECTOR Therapeutics, Inc. from 30 Jun 2022 to 31 Mar 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
eFFECTOR Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2022 to 31 Mar 2024.
  • eFFECTOR Therapeutics, Inc. Return On Equity for the quarter ending 31 Mar 2024 was 2178%.
  • eFFECTOR Therapeutics, Inc. annual Return On Equity for 2023 was 1194%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)

eFFECTOR Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2024 2178% +2651% 01 Jan 2024 31 Mar 2024
Q4 2023 1194% +1344% 01 Oct 2023 31 Dec 2023
Q3 2023 6229% +6198% +20235% 01 Jul 2023 30 Sep 2023
Q2 2023 -1126% -1302% -737% 01 Apr 2023 30 Jun 2023
Q1 2023 -472% 01 Jan 2023 31 Mar 2023
Q4 2022 -150% 01 Oct 2022 31 Dec 2022
Q3 2022 31% 01 Jul 2022 30 Sep 2022
Q2 2022 177% 01 Apr 2022 30 Jun 2022

eFFECTOR Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 1194% +1344% 01 Jan 2023 31 Dec 2023
2022 -150% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.